Dupont Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-2,083
| Closed | -$156K | – | 1826 |
|
2021
Q1 | $156K | Hold |
2,083
| – | – | ﹤0.01% | 1313 |
|
2020
Q4 | $180K | Buy |
+2,083
| New | +$180K | ﹤0.01% | 1150 |
|
2018
Q4 | – | Sell |
-4,500
| Closed | -$636K | – | 1216 |
|
2018
Q3 | $636K | Buy |
+4,500
| New | +$636K | 0.01% | 676 |
|
2018
Q2 | – | Sell |
-3,002
| Closed | -$484K | – | 1029 |
|
2018
Q1 | $484K | Hold |
3,002
| – | – | 0.01% | 682 |
|
2017
Q4 | $494K | Sell |
3,002
-10,526
| -78% | -$1.73M | 0.01% | 657 |
|
2017
Q3 | $843K | Hold |
13,528
| – | – | 0.02% | 562 |
|
2017
Q2 | $1.08M | Hold |
13,528
| – | – | 0.02% | 508 |
|
2017
Q1 | $961K | Hold |
13,528
| – | – | 0.02% | 534 |
|
2016
Q4 | $691K | Hold |
13,528
| – | – | 0.02% | 586 |
|
2016
Q3 | $623K | Buy |
+13,528
| New | +$623K | 0.01% | 540 |
|